Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients With Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group
Oncologist - United States
doi 10.1634/theoncologist.2019-0605
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2020
Authors
Publisher
Alphamed Press